| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 22, 2019 | 6.88 | 6.88 | 6.85 | 6.75 | 10,677 |
| Mar 21, 2019 | 6.61 | 6.61 | 6.61 | 6.75 | 50,000 |
| Mar 20, 2019 | 6.60 | 6.60 | 6.60 | 6.75 | 89,344 |
| Mar 19, 2019 | 6.60 | 6.60 | 6.60 | 6.75 | 40,000 |
| Mar 18, 2019 | 6.90 | 6.90 | 6.50 | 6.75 | 286,294 |
| Name | Tissue Regenix Group | Epic | TRX |
|---|---|---|---|
| ISIN | GB00B5SGVL29 | Currency | GBX |
| Type | Equity | Trading Segment | ASQ1 |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 15,000 | Prev Close | 6.75 |
| Shares in Issue (m) | 1,171.73 | Market Cap (£m) | 79.09 |
| PE Ratio | -6.75 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -1.00 | EPS Growth (%) | 22.48 |
| PEG | -0.30 | DPS Growth (%) | n/a |
| ROCE | -26.28 | Net Gearing | -22.25 |
| Quick Ratio | 4.31 | Current Ratio | 4.91 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 21 Jul | Jefferies International | Buy | 6.75 | 39.00 | 39.00 | Reiterates |
| 11 Jul | Jefferies International | Buy | 6.75 | 35.00 | 40.00 | Reiterates |
| 24 May | Jefferies International | Buy | 6.75 | 37.00 | 35.00 | Reiterates |
| 14 Mar | Jefferies International | Buy | 6.75 | 36.00 | 37.00 | Reiterates |
| 18 Jan | Jefferies International | Buy | 6.75 | 36.00 | 36.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 09 Aug 2017 | John Samuel | Buy | 2,000,000 @ 10.00p | £200,000.00 |
| 09 Aug 2017 | Alan Miller | Buy | 1,000,000 @ 10.00p | £100,000.00 |
| 09 Aug 2017 | Antony Odell | Buy | 150,000 @ 10.00p | £15,000.00 |
| 09 Aug 2017 | Jonathan Glenn | Buy | 600,000 @ 10.00p | £60,000.00 |
| 09 Aug 2017 | Steven Couldwell | Buy | 300,000 @ 10.00p | £30,000.00 |
